ESOMEPRAZOLE

SynDRA canonical compound SYN0023532 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ATP4A \| CYP2C19 \| CYP3A4
Mechanism of action	ATPase inhibitor
Indication	gastroesophageal reflux disease (GERD) \| peptic ulcer disease (PUD) \| Zollinger-Ellison syndrome
Disease area	gastroenterology

All known targets

esomeprazole magnesium dihydrate
(S)-Esomeprazole
(S)-Omeprazole
(-)-Omeprazole
esomeprazole magnesium
esomeprazole sodium
nexium control
esomeprazole magnesium hydrate
esomeprazole strontium
Esomeprazol
Omeprazole s-form
Inexium paranova
Omeprazole, (s)-
A02BC05
Esomeprazolum
Nexiam
Axagon (TN)
Esomeprazole (INN)
Esomeprazole [INN:BAN]
Esopral (TN)
Inexium paranova (TN)
Lucen (TN)
Nexiam (TN)
Nexium (TN)
Sompraz (TN)
Zoleri (TN)
(S)-(-)-Omeprazole
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole
H199/18
Omeprazole S-
N3PA6559FT
esomeprazol
esomeprazolum
Alenia
Esofag
Escz